Tue, Apr 22, 10:01 AM (24 days ago)
**Healthy Extracts Inc. (HYEX)** **Financial Performance:** - **Revenue:** $3,113,279 for 2024, up 25% from $2,485,866 in 2023. - **Net Income:** $(840,671) for 2024, improved from $(2,472,931) in 2023. - **Gross Profit:** $1,911,320 for 2024, up 54% from $1,621,810 in 2023. - **Operating Expenses:** $2,094,469 for 2024, down 34% from $3,865,654 in 2023. - **Earnings per Share:** $(0.28) for 2024, improved from $(0.85) in 2023. **Strategic Overview:** - Focus on increasing revenue, maintaining margins, and generating positive cash flow. - Platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals. - Key products target heart, brain, and immune health. - Subsidiaries: Bergamet NA, LLC (heart and immune health) and Ultimate Brain Nutrients, LLC (brain health). **Future Outlook:** - Plans to expand product portfolio and sales channels. - Strategic acquisitions to expand product portfolio. - Introduction of new products in gel-pack format and other health categories. **Risk Factors:** - Dependency on a single supplier for manufacturing. - Intense competition from larger, more established companies. - Regulatory risks and potential FDA actions. - Financial condition dependent on raising additional capital. - Market acceptance and customer retention risks. **Financial Condition:** - Net loss from inception to December 31, 2024: $19,240,344. - Cash resources at December 31, 2024: $112,020. - Financial statements prepared on a going concern basis. - Auditor's report reflects dependency on raising additional capital. **Market Position Changes:** - Quoted on OTCQB tier of OTC Markets Group under the symbol "HYEX." - Stock trades on a limited or sporadic basis. - No assurance of liquidity in the common stock. **Amendment Details:** - Amendment No. 1 on Form 10-K/A corrects the Date and Signature of Auditors Report. - No changes to the Original Filing and does not modify, amend, or update any financial or other information. - Does not reflect events subsequent to the Original Filing Date.